BRD9-Binding Moiety 1 Hydrochloride (CAT#: PRLG-001)
Please feel free to contact us for a quote and further discussion with our scientists.
Datasheets
| Specifications |
|---|
| Product Description |
BRD9-binding moiety 1 hydrochloride is a compound that binds to BRD9, and used for inhibiting BRD9 activity, based on Protein Degraders pathway. |
| Molecular Formula |
C₂₃H₂₆ClN₃O₇S₂ |
| Molecular Weight (Da) |
556.05 |
| Chemical Name |
(3-Chloro-5-methylsulfonylphenyl)methyl 2-(3-sulfamoylbenzoyl)-2,7-diazaspiro[3.5]nonane-7-carboxylate |
| Chemical Structure |
 |
| Purity |
98.2% |
| Solubility |
20.83 mg/mL (37.46 mM) in DMSO |
| Size |
5 mg |
| Physical State |
Powder |
| Storage |
The powder can be stored at 4°C for 2 years or at -20°C for 3 years. |
| Target Information |
|---|
| Target Name |
Bromodomain-containing Protein 9 |
| Alternative Names |
PRO9856; SMARCI2; LAVS3040; Rhabdomyosarcoma Antigen MU-RMS-40.8 |
| Introduction |
BRD9 is the component of SWI/SNF chromatin remodeling subcomplex GBAF that carries out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. |
| Gene ID |
65980 |
| UniProt ID |
Q9H8M2 |
| Related Disease |
BRD9-related disease |
Our services are For Research Use Only. We do not provide direct services for patients.
